Catalytic Health

Science For The Real World: Canadian Hematology Today

Health EN ↓ 7 episodes

Science for the Real World is designed to illuminate hot topics in Canadian healthcare through a series of conversations with Canadian clinicians. Canadian Hematology Today presents robust clinical perspectives and practical insights on the treatment and management of hematologic diseases. Hosted on Acast. See acast.com/privacy for more information.

Author

Catalytic Health

Episodes

Understanding the mechanism of BTK inhibitors 29.04.2026 24:51

Hosted on Acast. See acast.com/privacy for more information.

Strategic Sequencing in Relapsed Refractory Multiple Myeloma 13.01.2026 23:14

Hosted on Acast. See acast.com/privacy for more information.

Prise en charge des patients atteints de LLC doublement exposée et réfractaire. 18.11.2025 16:48

Hosted on Acast. See acast.com/privacy for more information.

Addressing the management of patients with double exposed and refractory CLL 18.11.2025 17:40

Sponsored by Eli Lilly Hosted on Acast. See acast.com/privacy for more information.

CAR T-cell Therapy in 2025: Evidence, Safety, and Patient Selection 24.09.2025 24:35

Sponsored by Bristol Myers Squibb. Hosted on Acast. See acast.com/privacy for more information.

Practical considerations in the management of early rrMM in the Canadian context 06.01.2025 32:00

This podcast features Dr. Christopher Venner and his colleagues from the hematology community, Dr. Sylvia McCulloch, Dr. Arleigh McCurdy, and Dr. Chai Phua discussing the approach to the management of early rrMM in the Canadian context. This episode of Science for the Real World is part of Canadian Hematology Today , an open-access scientific journal for the hematology community. Hosted on Acast....

The role of selinexor in early rrMM and sequencing in 2024. 26.06.2024 27:34

In this episode of "Science for the Real World: Canadian Hematology Today," Dr. Peter Anglin hosts a discussion with Dr. Joshua Richter and Dr. Darrell White on the management of early rrMM in 2024, focusing on the role of selinexor and treatment sequencing. Hosted on Acast. See acast.com/privacy for more information.